FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Pentagon plans to give South Korea primary role in deterring North Korea threats under new strategy

Minnesota ‘on the clock’ as HHS threatens penalties over childcare fraud scandal

Man who allegedly threatened to shoot ICE agents had rifles, body armor and ammo cache, feds say

RNC regroups and recalibrates for midterm election fight

Anonymous letter to California GOP chapter calls for war on ICE, urges agents be sent ‘home in a body bag’

Thousands march through Minneapolis, swarm Target Center demanding ICE removal from Minnesota

Christians Beaten, Abducted in Nigeria as Church Service Attacked, Prayer Books Desecrated, and Worship Instruments Broken

GOP Rep. Releases Footage to Preemptively Crush Democrats’ ICE Detention Facility Stunt

Mamdani clarifies NYC won’t check immigration status for universal childcare enrollees

House Passes Law Forcing Universities to Give Pregnant Students Information on Keeping Their Children Instead of Aborting Them

Watch: JD Vance Tells the Uncomfortable Truth About Abortion at March for Life

California sues Trump administration over allegedly ‘unlawful’ pipeline restart approval years after oil spill

Trump’s pardon of House Dem Cuellar back in the spotlight as his brother faces indictment

Mike Johnson Tells March for Life Attendees His Teen Parents Were Told to Abort Him, Is ‘Eternally Grateful’ They Refused

Judge’s rejection of Don Lemon charges faces conflict of interest concerns

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”